A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06218290 |
Recruitment Status :
Active, not recruiting
First Posted : January 23, 2024
Last Update Posted : March 15, 2024
|
Sponsor:
Unicycive Therapeutics, Inc
Information provided by (Responsible Party):
Unicycive Therapeutics, Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | March 31, 2024 |
Estimated Study Completion Date : | March 31, 2024 |